Pages that link to "Q80152192"
Jump to navigation
Jump to search
The following pages link to Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study (Q80152192):
Displaying 30 items.
- Sublingual immunotherapy for asthma (Q24187736) (← links)
- Sublingual immunotherapy for treating allergic conjunctivitis (Q24235657) (← links)
- Particularities of allergy in the Tropics (Q26314626) (← links)
- Sublingual immunotherapy: World Allergy Organization position paper 2013 update (Q30440195) (← links)
- Recombinant house dust mite allergens. (Q34361546) (← links)
- Progress in the management of childhood asthma (Q35718674) (← links)
- Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso (Q35777126) (← links)
- Sublingual Immunotherapy for Asthmatic Children Sensitized to House Dust Mite: A Meta-Analysis (Q36194445) (← links)
- Predictive value of IgE/IgG4 antibody ratio in children with egg allergy (Q36438797) (← links)
- Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper (Q36834756) (← links)
- House dust allergy and immunotherapy (Q36863569) (← links)
- Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations (Q36994648) (← links)
- Subcutaneous and sublingual immunotherapy in children: complete update on controversies, dosing, and efficacy (Q37304729) (← links)
- New types of immunotherapy in children. (Q37304734) (← links)
- Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma (Q37350287) (← links)
- Sublingual immunotherapy in children: an updated review (Q37488131) (← links)
- Therapeutic manipulation of immune tolerance in allergic disease (Q37567423) (← links)
- Subcutaneous Versus Sublingual Immunotherapy for Allergic Rhinitis and/or Asthma (Q37888684) (← links)
- Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review (Q38104712) (← links)
- Clinical and Immunologic Effects of Sublingual Immunotherapy on Patients with Allergic Rhinitis to House-Dust Mites: 1-Year follow-up Results (Q38481969) (← links)
- Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis (Q39649421) (← links)
- Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children. (Q41383161) (← links)
- Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy (Q41776008) (← links)
- The placebo effect in allergen-specific immunotherapy trials (Q41846193) (← links)
- Mucosal immunity and sublingual immunotherapy in respiratory disorders (Q42071106) (← links)
- Applications and mechanisms of immunotherapy in allergic rhinitis and asthma (Q47653403) (← links)
- Sub-lingual immunotherapy: world allergy organization position paper 2009. (Q55527154) (← links)
- Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites (Q57279742) (← links)
- Cochrane Review: Sublingual immunotherapy for treating allergic conjunctivitis (Q64447287) (← links)
- Sublingual immunotherapy is safe in children, but the challenge is how to increase its efficiency? (Q84160601) (← links)